- E29.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E29.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E29.1 – other international versions of ICD-10 E29.1 may differ.
ICD-10-CM E29.1 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Defective biosynthesis of testicular androgen NOS
- 5-delta-Reductase deficiency (with male pseudohermaphroditism)
- Testicular hypogonadism NOS
Type 1 Excludes
- postprocedural testicular hypofunction (E89.5)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E29.1:
- biosynthesis, testicular androgen > Abnormal, abnormality, abnormalities
- biosynthesis, androgen (testicular) > Defect, defective Q89.9
- 5-alpha reductase (with male pseudohermaphroditism) > Deficiency, deficient
- testicular > hormone E23.0
- Leydig\’s cell, adult > Failure, failed
- seminiferous tubule, adult > Failure, failed
- testicular endocrine function > Failure, failed
- testicular > Hypofunction
- male > Hypogonadism
- testicular (primary) > Hypogonadism
- testis > Infantile
- testis > gonadal E28.39
- testis > Insufficiency, insufficient
- 5-alpha-reductase deficiency > with E25.8
- prepubertal castrate > functional K59.9
- testis > Undeveloped, undevelopment